P

PLx Pharma Inc
F:1D5A

Watchlist Manager
PLx Pharma Inc
F:1D5A
Watchlist
Price: 0.0005 EUR Market Closed
Market Cap: €210k

Cash Flow Statement

Cash Flow Statement
PLx Pharma Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Jun-2013 Sep-2013 Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022
Operating Cash Flow
Net Income
(3)
(2)
(4)
(6)
(10)
(13)
(14)
(15)
(15)
(17)
(19)
(20)
(13)
(9)
(5)
(1)
(6)
(9)
(15)
(9)
(10)
(10)
1
(15)
(21)
(16)
(21)
(8)
(4)
(9)
(15)
(28)
(39)
(58)
(46)
(45)
(41)
(28)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Deffered Taxes
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(1)
(1)
(1)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Non-Cash Items
1
0
1
2
2
2
2
3
3
4
4
4
3
3
2
1
2
2
5
(3)
(2)
(2)
(11)
5
9
3
7
(5)
(9)
(3)
3
16
24
36
8
(6)
(19)
(31)
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
0
0
0
1
0
0
0
(1)
(0)
(0)
Change in Working Capital
(0)
0
1
0
0
1
0
0
0
(1)
0
0
1
1
1
0
(1)
(0)
(2)
(2)
(1)
(1)
0
1
2
1
1
0
(0)
(1)
(0)
(1)
(1)
(0)
6
7
2
(1)
Cash from Operating Activities
(2)
N/A
(2)
+23%
(2)
-39%
(4)
-91%
(7)
-76%
(9)
-26%
(11)
-22%
(12)
-7%
(12)
+2%
(13)
-14%
(15)
-8%
(17)
-14%
(9)
+43%
(5)
+43%
(2)
+66%
1
N/A
(7)
N/A
(8)
-21%
(13)
-66%
(15)
-12%
(13)
+11%
(13)
+2%
(10)
+26%
(9)
+5%
(10)
-6%
(11)
-18%
(13)
-12%
(13)
-4%
(13)
-2%
(13)
+0%
(12)
+8%
(13)
-4%
(15)
-21%
(21)
-38%
(32)
-51%
(45)
-39%
(57)
-28%
(59)
-3%
Investing Cash Flow
Capital Expenditures
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(1)
(1)
(1)
(1)
(1)
(0)
0
(0)
(0)
(0)
0
(0)
(0)
(0)
0
0
0
0
0
0
Other Items
0
0
0
0
0
0
0
0
(12)
(27)
(27)
(23)
(15)
0
0
0
12
12
12
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
(12)
N/A
(27)
-125%
(27)
+0%
(23)
+15%
(15)
+35%
0
N/A
0
N/A
(4)
N/A
12
N/A
12
-1%
11
-3%
11
-2%
(1)
N/A
(1)
+12%
(1)
+34%
(0)
+40%
0
N/A
(0)
N/A
(0)
-77%
(0)
+4%
0
N/A
(0)
N/A
(0)
+50%
(0)
N/A
(0)
+45%
0
N/A
0
+0%
0
N/A
0
N/A
0
-99%
Financing Cash Flow
Net Issuance of Common Stock
4
5
5
38
37
35
34
0
20
20
20
0
0
0
0
0
17
24
24
0
7
0
0
14
14
16
16
2
9
8
25
91
85
96
80
13
13
3
Net Issuance of Debt
0
0
0
0
0
0
0
0
0
0
0
0
1
2
2
4
3
3
3
0
0
0
0
(0)
(1)
(2)
(3)
(4)
(4)
(4)
(4)
(3)
(2)
(2)
(1)
0
0
0
Cash from Financing Activities
4
N/A
5
+22%
5
-11%
38
+730%
37
-4%
35
-4%
34
-3%
0
N/A
20
N/A
20
-1%
20
N/A
0
N/A
1
N/A
2
+15%
2
+19%
4
+144%
20
+351%
27
+36%
26
-1%
24
-10%
7
-70%
0
N/A
0
N/A
13
N/A
13
-4%
13
+4%
13
-6%
(2)
N/A
6
N/A
4
-27%
21
+403%
88
+323%
82
-6%
95
+15%
79
-17%
13
-84%
13
+1%
3
-80%
Change in Cash
Net Change in Cash
2
N/A
4
+63%
2
-33%
34
+1 315%
29
-13%
26
-11%
23
-11%
(12)
N/A
(4)
+67%
(21)
-423%
(22)
-5%
(20)
+9%
(23)
-17%
(4)
+83%
(0)
+99%
1
N/A
25
+1 652%
30
+23%
24
-20%
20
-18%
(7)
N/A
(14)
-94%
(10)
+27%
4
N/A
3
-15%
2
-41%
(0)
N/A
(15)
-5 912%
(8)
+47%
(9)
-18%
8
N/A
75
+789%
67
-11%
73
+10%
47
-36%
(32)
N/A
(44)
-39%
(57)
-28%
Free Cash Flow
Free Cash Flow
(2)
N/A
(2)
+23%
(2)
-39%
(4)
-91%
(7)
-76%
(9)
-26%
(11)
-22%
(12)
-7%
(12)
+2%
(13)
-14%
(15)
-8%
(17)
-14%
(9)
+43%
(5)
+43%
(2)
+66%
1
N/A
(7)
N/A
(8)
-23%
(14)
-69%
(16)
-13%
(14)
+9%
(14)
+3%
(10)
+27%
(9)
+7%
(10)
-1%
(11)
-20%
(13)
-13%
(13)
-4%
(13)
N/A
(14)
-1%
(12)
+9%
(13)
-4%
(15)
-20%
(21)
-38%
(32)
-51%
(45)
-39%
(57)
-28%
(59)
-3%